UNIVERSAL STAINLESS & ALLOY (USAP)

US9138371003 - Common Stock

43.92  -0.13 (-0.3%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to USAP. USAP was compared to 155 industry peers in the Metals & Mining industry. USAP has only an average score on both its financial health and profitability. USAP is not valued too expensively and it also shows a decent growth rate.



5

1. Profitability

1.1 Basic Checks

In the past year USAP was profitable.
USAP had a positive operating cash flow in the past year.
In multiple years USAP reported negative net income over the last 5 years.
In multiple years USAP reported negative operating cash flow during the last 5 years.

1.2 Ratios

USAP's Return On Assets of 7.17% is amongst the best of the industry. USAP outperforms 80.65% of its industry peers.
With a decent Return On Equity value of 10.52%, USAP is doing good in the industry, outperforming 78.06% of the companies in the same industry.
USAP has a better Return On Invested Capital (9.28%) than 83.87% of its industry peers.
Industry RankSector Rank
ROA 7.17%
ROE 10.52%
ROIC 9.28%
ROA(3y)-0.36%
ROA(5y)-1.24%
ROE(3y)-0.62%
ROE(5y)-1.7%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 8.14%, USAP is in the better half of the industry, outperforming 79.35% of the companies in the same industry.
USAP's Profit Margin has declined in the last couple of years.
USAP has a better Operating Margin (11.59%) than 67.10% of its industry peers.
In the last couple of years the Operating Margin of USAP has declined.
USAP has a Gross Margin (21.62%) which is comparable to the rest of the industry.
USAP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.59%
PM (TTM) 8.14%
GM 21.62%
OM growth 3YN/A
OM growth 5Y-5.23%
PM growth 3YN/A
PM growth 5Y-16.31%
GM growth 3YN/A
GM growth 5Y-0.33%

6

2. Health

2.1 Basic Checks

USAP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, USAP has more shares outstanding
USAP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, USAP has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 4.40 indicates that USAP is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.40, USAP is in the better half of the industry, outperforming 69.03% of the companies in the same industry.
The Debt to FCF ratio of USAP is 3.64, which is a good value as it means it would take USAP, 3.64 years of fcf income to pay off all of its debts.
USAP has a better Debt to FCF ratio (3.64) than 72.26% of its industry peers.
USAP has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
USAP has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 3.64
Altman-Z 4.4
ROIC/WACC0.82
WACC11.33%

2.3 Liquidity

USAP has a Current Ratio of 4.38. This indicates that USAP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.38, USAP is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
A Quick Ratio of 1.35 indicates that USAP should not have too much problems paying its short term obligations.
USAP has a Quick ratio (1.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.38
Quick Ratio 1.35

6

3. Growth

3.1 Past

USAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1694.12%, which is quite impressive.
Measured over the past years, USAP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.94% on average per year.
Looking at the last year, USAP shows a very strong growth in Revenue. The Revenue has grown by 24.80%.
Measured over the past years, USAP shows a small growth in Revenue. The Revenue has been growing by 2.24% on average per year.
EPS 1Y (TTM)1694.12%
EPS 3YN/A
EPS 5Y-16.94%
EPS Q2Q%455%
Revenue 1Y (TTM)24.8%
Revenue growth 3Y16.75%
Revenue growth 5Y2.24%
Sales Q2Q%22.47%

3.2 Future

Based on estimates for the next years, USAP will show a very strong growth in Earnings Per Share. The EPS will grow by 156.90% on average per year.
USAP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.33% yearly.
EPS Next Y546%
EPS Next 2Y156.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.33%
Revenue Next 2Y6.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.21 indicates a correct valuation of USAP.
70.97% of the companies in the same industry are more expensive than USAP, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of USAP to the average of the S&P500 Index (27.54), we can say USAP is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.05, the valuation of USAP can be described as correct.
63.87% of the companies in the same industry are more expensive than USAP, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.99, USAP is valued a bit cheaper.
Industry RankSector Rank
PE 16.21
Fwd PE 13.05

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USAP indicates a somewhat cheap valuation: USAP is cheaper than 65.81% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USAP indicates a somewhat cheap valuation: USAP is cheaper than 74.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.51
EV/EBITDA 8.2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
USAP's earnings are expected to grow with 156.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y156.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

USAP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UNIVERSAL STAINLESS & ALLOY

NASDAQ:USAP (12/26/2024, 11:07:00 AM)

43.92

-0.13 (-0.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)N/A N/A
Inst Owners66.11%
Inst Owner Change8.17%
Ins Owners6.18%
Ins Owner Change2.25%
Market Cap408.90M
Analysts43.33
Price Target46.92 (6.83%)
Short Float %3.4%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.19%
Min EPS beat(2)6.69%
Max EPS beat(2)69.68%
EPS beat(4)3
Avg EPS beat(4)22.71%
Min EPS beat(4)-17.28%
Max EPS beat(4)69.68%
EPS beat(8)7
Avg EPS beat(8)31.78%
EPS beat(12)8
Avg EPS beat(12)11.84%
EPS beat(16)10
Avg EPS beat(16)11.48%
Revenue beat(2)2
Avg Revenue beat(2)1.25%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.54%
Revenue beat(4)2
Avg Revenue beat(4)-0.47%
Min Revenue beat(4)-3.81%
Max Revenue beat(4)1.54%
Revenue beat(8)4
Avg Revenue beat(8)0.96%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)7
Avg Revenue beat(16)-1.25%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)43.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.56%
Valuation
Industry RankSector Rank
PE 16.21
Fwd PE 13.05
P/S 1.25
P/FCF 21.51
P/OCF 11.12
P/B 1.61
P/tB 1.61
EV/EBITDA 8.2
EPS(TTM)2.71
EY6.17%
EPS(NY)3.37
Fwd EY7.66%
FCF(TTM)2.04
FCFY4.65%
OCF(TTM)3.95
OCFY9%
SpS35.17
BVpS27.2
TBVpS27.2
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.17%
ROE 10.52%
ROCE 11.74%
ROIC 9.28%
ROICexc 9.28%
ROICexgc 9.28%
OM 11.59%
PM (TTM) 8.14%
GM 21.62%
FCFM 5.81%
ROA(3y)-0.36%
ROA(5y)-1.24%
ROE(3y)-0.62%
ROE(5y)-1.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-4.38%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.38%
OM growth 3YN/A
OM growth 5Y-5.23%
PM growth 3YN/A
PM growth 5Y-16.31%
GM growth 3YN/A
GM growth 5Y-0.33%
F-Score8
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 3.64
Debt/EBITDA 1.12
Cap/Depr 86.51%
Cap/Sales 5.43%
Interest Coverage 250
Cash Conversion 62.9%
Profit Quality 71.33%
Current Ratio 4.38
Quick Ratio 1.35
Altman-Z 4.4
F-Score8
WACC11.33%
ROIC/WACC0.82
Cap/Depr(3y)62.34%
Cap/Depr(5y)64.96%
Cap/Sales(3y)5.89%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1694.12%
EPS 3YN/A
EPS 5Y-16.94%
EPS Q2Q%455%
EPS Next Y546%
EPS Next 2Y156.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.8%
Revenue growth 3Y16.75%
Revenue growth 5Y2.24%
Sales Q2Q%22.47%
Revenue Next Year16.33%
Revenue Next 2Y6.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y555.2%
EBIT growth 3YN/A
EBIT growth 5Y-3.1%
EBIT Next Year348.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y154.35%
FCF growth 3Y-5.9%
FCF growth 5Y58.5%
OCF growth 1Y289.52%
OCF growth 3Y1.95%
OCF growth 5Y8.72%